rss
J Clin Pathol 2004;57:1160-1164 doi:10.1136/jcp.2004.016238
  • Original article

ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival

  1. W Weichert1,
  2. T Knösel1,
  3. J Bellach2,
  4. M Dietel1,
  5. G Kristiansen1
  1. 1Institute of Pathology, Charité University Hospital, D-10117 Berlin, Germany
  2. 2Tumour Centre, Charité University Hospital
  1. Correspondence to:
 Dr G Kristiansen
 Institute of Pathology, Charité Hospital, Campus Mitte, Schumannstr. 20/21, D-10117 Berlin, Germany; glen.kristiansencharite.de
  • Accepted 19 April 2004

Abstract

Background: Activated leucocyte cell adhesion molecule (ALCAM) has been implicated in tumorigenesis and tumour progression of malignant melanoma and prostate cancer.

Aims: To clarify the expression patterns of ALCAM in colon cancer and to correlate these with clinicopathological parameters, including patient survival.

Methods: One hundred and eleven colorectal carcinomas were immunostained for ALCAM (clone MOG/07) using a standard detection system. Cytoplasmic and membranous immunoreactivity were scored semiquantitatively. Fisher’s exact test, χ2 test for trends, Kaplan–Meier analysis, and Cox’s regression were applied.

Results: In colorectal cancer, 58.6% and 30.6% of cases showed strong cytoplasmic and membranous expression of ALCAM, respectively. No significant correlation with patient age, tumour grade, stage, or nodal status was apparent. In survival analyses, membranous ALCAM expression correlated significantly (Cox’s regression, p  =  0.028; relative risk, 2.3) with shortened patient survival.

Conclusions: ALCAM is frequently upregulated in colorectal cancer and is a new independent prognostic marker, underscoring the importance of ALCAM in tumour progression in this disease.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.